SPRO Dana dhuwit perusahaan Spero Therapeutics, Inc.

Logo grafis sperotherapeutics.com (SPRO)

The potential for monopoly revenues from antibiotic patents is driving the cash balance dynamics of Spero Therapeutics (SPRO). The foundation of Spero Therapeutics (SPRO) rests on the deep scientific expertise of its staff and business protection provided by stringent FDA requirements. The current level of 0.11 shows the value of this metric, allowing for an assessment of liquidity resilience against Fed rates and inflationary risks on this chart.

Total volume dana dhuwit perusahaan: Spero Therapeutics Inc (SPRO) kanggo 04.07.2022 - 21.11.2026

Rincian metrik keuangan lan pasar Spero Therapeutics Inc (SPRO)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:Spero Therapeutics SPRO
Produk mawa merek Spero Therapeutics, Inc.

This indicator assesses the liquid safety cushion, determining the business's ability to fund development or service debt without external borrowing. Analyzing the current size of cash assets allows for the identification of the stage between capital accumulation and expansion, which is critical for Spero Therapeutics (SPRO) when scaling antibiotic supplies to the hospital sector to ensure long-term operational sustainability.